WikiMD's Wellness Encyclopedia
WikiMD's Wellness Encyclopedia
Search
Log in
↓
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Navigation menu
Navigation
Main page
Current events
Recent changes
Popular pages
Random page
Upload file
Special pages
WikiMD St@tistics
Wellness matters
Wellness
Diet
Recipes
Weight loss diet
Medical weight loss NYC
Brooklyn weight loss
Encyclopedia
Health encyclopedia
Disease index
Health topics
Glossaries
Rare diseases
Directory
Doctor finder (US)
World Directory
Sister projects
Christian Encyclopedia
Medical weight loss NYC
Medical directory
Sponsors
NYC physician weight loss
Philadelphia medical weight loss
NYC sleep clinic
Philadelphia sleep clinic
Lose weight NYC
Indian vegetable farm NJ
W8MD weight loss centers
Contact
Contact us
Navigation
Speci@l PageS
Template
:
Monoclonals for immune system
From WikiMD's Wellness Encyclopedia
Monoclonal antibodies
for the
immune system
Immune system
Human
*
Immunosuppression
:
Abrilumab
Adalimumab
#
Anifrolumab
Atorolimumab
Avelumab
Avdoralimab
Belimumab
Bleselumab
Brodalumab
Camidanlumab tesirine
Carlumab
Cemiplimab
Dupilumab
Eldelumab
Emapalumab
Fresolimumab
Golimumab
Ianalumab
†
Lanadelumab
Lenzilumab
Lerdelimumab
Lirentelimab
Lirilumab
Mavrilimumab
Metelimumab
Morolimumab
Namilumab
Oleclumab
Oxelumab
§
Pamrevlumab
Placulumab
Relatlimab
†
Sarilumab
Sifalimumab
Tabalumab
Tezepelumab
Ulocuplumab
Varlilumab
Immune activation
:
Ipilimumab
Durvalumab
Nivolumab
Tremelimumab
Urelumab
Other
:
Bertilimumab
Ontamalimab
Zanolimumab
Combination
:
Nivolumab/relatlimab
Mouse
*
Afelimomab
Elsilimomab
Faralimomab
Gavilimomab
Inolimomab
Maslimomab
Nerelimomab
Odulimomab
Telimomab aritox
Vepalimomab
Zolimomab aritox
Chimeric
*
Andecaliximab
†
Basiliximab
Clenoliximab
Galiximab
Gomiliximab
Infliximab
Keliximab
Lumiliximab
Priliximab
Teneliximab
Vapaliximab
Humanized
*
Immunosuppressive:
Apolizumab
§
Aselizumab
Atezolizumab
Benralizumab
Camrelizumab
†
Cedelizumab
Certolizumab pegol
Crizanlizumab
Daclizumab
Eculizumab
Efalizumab
‡
Epratuzumab
Erlizumab
Etrolizumab
†
Fontolizumab
Frexalimab
†
Inebilizumab
Itolizumab
Lampalizumab
†
Letolizumab
Ligelizumab
†
Lulizumab pegol
Mepolizumab
Mogamulizumab
Natalizumab
Ocrelizumab
(
+hyaluronidase
)
Omalizumab
Ozoralizumab
Pascolizumab
Pateclizumab
Pembrolizumab
Pexelizumab
Pidilizumab
Plozalizumab
PRO 140
†
Quilizumab
Ravulizumab
Reslizumab
Retifanlimab
Rontalizumab
Rovelizumab
Ruplizumab
Samalizumab
Satralizumab
Siplizumab
Spartalizumab
†
Talizumab
Teclistamab
Teplizumab
Tislelizumab
Tocilizumab
Toralizumab
Tregalizumab
Vatelizumab
Vedolizumab
Visilizumab
Vobarilizumab
TGN1412
§
Immune activation
:
Dostarlimab
Other:
Ibalizumab
Chimeric + humanized
*
Otelixizumab
Rozanolixizumab
Sutimlimab
Interleukin
Human
*
Bermekimab
Brazikumab
Briakinumab
Canakinumab
Fezakinumab
Fletikumab
Guselkumab
Secukinumab
Sirukumab
Tralokinumab
Ustekinumab
Humanized
*
Anrukinzumab
Bimekizumab
Clazakizumab
Gevokizumab
Ixekizumab
Mirikizumab
†
Lebrikizumab
Olokizumab
†
Perakizumab
Risankizumab
Spesolimab
Tildrakizumab
Veterinary
*
Lokivetmab
Inflammatory
lesions
Mouse
*
Besilesomab
Fanolesomab
‡
Lemalesomab
Sulesomab
#
WHO-EM
‡
Withdrawn
from market
Clinical trials
:
†
Phase III
§
Never to phase III
Category
:
Monoclonal antibody templates